mRNA-4106

· ModernaTX, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mRNA-4106, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study of mRNA-4106 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Solid Tumors [Phase 1]

See pricing